(Unterschied) ← Nächstältere Version | Aktuelle Version (Unterschied) | Nächstjüngere Version → (Unterschied)
32455629 2020. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
32636851 2020. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).
32745548 2020. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.
| 32837891 2020. The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.
|
| 32957884 2020. Quercetin and its relative therapeutic potential against COVID-19: A retrospective review and prospective overview.
|
33016666 2020. Quercetin Phytosome(R) as a potential candidate for managing COVID-19.
33034398 2020. A role for quercetin in coronavirus disease 2019 (COVID-19).
| 33179911 2020. Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity.
|
| 33200026 2020. Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor.
|
